The ups and downs of elevator‐type di‐/tricarboxylate membrane transporters-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The ups and downs of elevator‐type di‐/tricarboxylate membrane transporters

Published:2021-08-24 Issue: Volume: Page:
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Sauer David B.¹²,Wang Bing³,Sudar Joseph C.¹,Song Jinmei¹,Marden Jennifer¹,Rice William J.³,Wang Da‐Neng¹⁴^ORCID

Affiliation:

1. Skirball Institute of Biomolecular Medicine New York University School of Medicine NY USA

2. ^* Centre for Medicines Discovery Nuffield Department of Medicine University of Oxford UK

3. Cryo‐Electron Microscopy Core New York University School of Medicine NY USA

4. Department of Cell Biology New York University School of Medicine NY USA

Funder

Pfizer

U.S. Department of Defense

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16158

Reference54 articles.

1. The SLC13 gene family of sodium sulphate/carboxylate cotransporters;Markovich D;Pflug Arch Eur J Phy,2004

2. SLC13 family of Na+‐coupled di‐ and tri‐carboxylate/sulfate transporters;Bergeron MJ;Mol Aspects Med,2013

3. Sodium‐coupled dicarboxylate and citrate transporters from the SLC13 family;Pajor AM;Pflugers Arch,2014

4. Structural basis for the reaction cycle of DASS dicarboxylate transporters;Sauer DB;eLife

5. The ion transporter superfamily;Prakash S;Biochim Biophys Acta,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pho pictures provide powerful perspectives of phosphate importing proteins;Structure;2024-07

2. Molecular phenotypes segregate missense mutations in SLC13A5 Epilepsy;2024-05-23

3. TRAPs: the ‘elevator-with-an-operator’ mechanism;Trends in Biochemical Sciences;2024-02

4. Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery;Journal of Medicinal Chemistry;2023-07-10

5. Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders;Molecular and Cellular Biochemistry;2022-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3